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Laurence Weinberg, MD,* Lachlan F. Miles, MD,† Maysana Allaf, MD,† Param Pillai, MD,† Philip Peyton, MD,†
and Laurie Doolan, MD‡Objectives: To determine whether video ﬂuoroscopy com-
bined with traditional pressure waveform analyses facili-
tates optimal pulmonary artery catheter (PAC) ﬂotation and
ﬁnal positioning compared with the traditional pressure
waveform ﬂotation technique alone.
Design: Prospective, single-center, randomized, controlled
trial.
Setting: Single-center university teaching hospital.
Participants: The study included 50 cardiac surgery
patients at higher risk for PAC complications.
Interventions: Use of video ﬂuoroscopy to facilitate opti-
mal PAC ﬂotation and positioning.
Measurements and Main Results: The primary outcome
was the time taken to ﬂoat and position the PAC balloon in
the pulmonary artery as conﬁrmed by transesophageal
echocardiography. Secondary outcomes included number
of attempts at ﬂotation, ventricular rhythm disturbances,
and catheter malposition. Patients were evenly matched in
baseline demographics, New York Heart Association symp-
toms of heart failure, severity of left and right ventri-
cular dysfunction, end-diastolic pressures and dimensions,Journal of Cardiothoracic and Vascular Anesthesia, Vol 29, No 6 (Decembseverity of tricuspid valvular disease, and atrial and pulmo-
nary artery pressures. Mean (SD) time to ﬂoat the PAC was
signiﬁcantly shorter in the video ﬂuoroscopy group than in
the usual care group: 73 seconds (SD, 65.1) versus 176
seconds (SD, 180.6), respectively; p ¼ 0.014. The median
(interquartile range [IQR]) number of attempts to successful
ﬂotation was fewer in the video ﬂuoroscopy group than in
the usual care group: 1 (IQR 1:2) attempt versus 2 (IQR 1:4)
attempts, respectively; p ¼ 0.007. The composite complica-
tion rate (malposition and arrhythmias) was lower in the
video ﬂuoroscopy group than in the usual care group (16% v
52%, respectively; p ¼ 0.01).
Conclusions: In cardiac surgery patients at higher risk for
PAC complications, video ﬂuoroscopy facilitated faster and
safer catheter ﬂotation and positioning compared with the
traditional pressure waveform ﬂotation technique.
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http://dx.doi.org/10.1053/j.jvca.2015.07.033SINCE THEIR INTRODUCTION in clinical practice 4decades ago, balloon-tipped, ﬂow-directed pulmonary
artery catheters (PACs) have found widespread use in the
clinical management of critically ill patients undergoing cardiac
surgery. The PAC originally was developed as a “balloon-
tipped catheter” to be used at the bedside without requiring
radiology or ﬂuoroscopy for insertion. PAC-derived hemody-
namic data can provide information critical to the effective
management of critically ill patients, even if other monitoring
modalities, such as transesophageal echocardiography (TEE),
are used.1,2 Correct positioning of the PAC in the pulmonary
artery (PA) is essential for its safe use, and pressure waveform
analysis is the most common method used to guide ﬂotation of
the PAC tip into position. However, due to abnormal or slow
intracardiac blood ﬂow, this technique may be difﬁcult in
patients with poor cardiac function or severe valvular heart
disease, resulting in repeated attempts at ﬂotation, arrhythmias,
and catheter malposition. Therefore, in patients undergoing
cardiac surgery who are considered at higher risk for PAC
complications, the authors hypothesized that video ﬂuoroscopy
combined with pressure waveform analysis would achieve a
faster, more reliable and therefore safer catheter ﬂotation and
ﬁnal positioning compared with the traditional pressure wave-
form ﬂotation technique alone.
METHODS
After receiving Austin Health Research Ethics Committee
approval (H2009/03740) and written informed participant
consent, the authors conducted a single-center, randomized,
clinical trial between July 2010 and July 2012 at a university
teaching hospital that is experienced in complex cardiac
surgery. The study was registered with the Australian New
Zealand Clinical Trials Registry (number: 12614001081606).Inclusion criteria included adult patients considered to be at
higher risk for difﬁcult PAC insertion who were undergoing
elective or semi-urgent cardiac surgery that necessitated a PAC
as part of routine perioperative care. Because there are no
validated criteria for patients at “high risk” for difﬁcult PAC
insertion, the authors deﬁned “high-risk” as 1 or more of the
following criteria: left ventricular ejection fractiono35%, low-
cardiac-output syndrome (cardiac indexo1.5 L/min/m2),
severe pulmonary hypertension (mean pulmonary artery pres-
sure440 mmHg), and severe tricuspid insufﬁciency. Criteria
for inclusion were obtained from routine preoperative trans-
thoracic or transesophageal echocardiography, coronary
angiography, and right heart catheterization studies. Exclusion
criteria included ageo18 years, inability to provide informed
and written consent (eg, patients awaiting surgery in the
intensive care unit who had been administered sedatives), and
time-critical surgery in which induction of anesthesia was
imperative before the PAC being inserted (eg, acute aortic
dissection). Patients were assigned randomly into 2 groups using a
computer-generated program: those in whom the PAC was ﬂoated
using video ﬂuoroscopy combined with real-time pressureer), 2015: pp 1511–1516 1511
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PAC was ﬂoated by real-time pressure waveform monitoring alone
(usual-care group). If the PAC was unable to be ﬂoated within a 10-
minute period, patients were transferred to the alternative group.
Three senior consultant cardiac anesthesiologists, who are
proﬁcient in PAC insertion and video ﬂuoroscopy, performed
all PAC insertions using a protocol designed to standardize care
in both groups. On arrival to the operating room, all patients
underwent placement of a peripheral intravenous cannula and
an arterial blood pressure monitoring line. A conscious sedation
technique with midazolam (0.02-0.05 mg/kg) and fentanyl
(0.5 ug/kg) was used to place patients supine in the Trendelen-
berg position (30-degree tilt of the bed below horizontal, with
the head in lowest position) on a standard radiolucent operating
room table. Per the authors’ institution’s radiology protocols,
the anesthesiologists were not required to wear a dosimeter
because the procedure was performed in the cardiac opera-
ting room and screening times were of very short duration.
A trained radiologist operated the ﬂuoroscopy machine. In keeping
with stringent hospital policy, protective garments, including
thyroid shielding, were worn by all personnel. The standard
garment worn is a 0.5-mm lead apron, which stops approximately
95% of the scatter radiation. Fixed screening barriers provided
additional protection from scattered radiation for all personnel,
except for the anesthesiologist performing the procedure. Using
real-time ultrasound guidance and the standard aseptic Seldinger
technique, a 9-French Arrow-Flex Sheath (Teleﬂex Inc., Morris-
ville, NC) was inserted into the internal jugular vein of all patients.
The PAC sheath was primed with normal saline and sutured to the
neck. A Swan-Ganz CCOmbo PAC (Edwards Lifesciences, Irvine,
CA) was prepared per normal protocol and used in all patients.
Technique for PAC Flotation in the Usual-Care Group1. The distal port of the PAC was connected to a pressure
transducer and monitor.2. The patient was repositioned by rotating the operating
table 15 degrees to the right from the supine position in
the reverse Trendelenberg position (30-degree tilt of the bed
above the horizontal, with the head in the highest position).3. The patient was connected to an electrocardiograph, which
continuously recorded the electrocardiogram (ECG) tracing.4. An independent research nurse started timing when the
catheter was inserted 5 cm into the PAC sheath. Two
stopwatches were used for timing.5. When the catheter tip ﬁrst entered the vessel lumen and
oscillations appeared on the pressure tracing, the balloon
was inﬂated with 1.5 mL of air.6. The catheter then was advanced continually at a rate of 2 cm
every second using slow continuous motions and rotated as
required by the operator. Conventional pressure waveform
analyses were used to identify the position of the PAC as it
traversed from the superior vena cava (SVC) into the right
atrium (RA) (central venous pressure trace), into the right
ventricle ([RV] pressure trace), and then into the PA (PA
pressure waveform trace).Fig 1. Video ﬂuoroscopy image demonstrating the normal posi-7.
tion of the pulmonary artery catheter tip in the right pulmonary
artery.The number of attempts at insertion were recorded. An
attempt was deﬁned as the necessity to withdraw the catheter
back into the RV, RA, or SVC to assist with PAC insertion.8. If more than 4 attempts to advance the catheter into the PA
were unsuccessful, the following technique was used to
facilitate placement of the PAC in the PA:
First, the catheter was removed from the PA sheath and
“stiffened” by ﬂushing 20 mL of cold normal saline at a
temperature of 41C through it after its tip was bent into a three-
fourths circle. Three further attempts to position the PAC in the
PA were allowed.1. When the anesthesiologist was satisﬁed that the catheter
was in an optimum position in the PA, timing was stopped
and the catheter was secured.2. If the PAC was unable to be ﬂoated into the PA within 10
minutes, patients were transferred to the video ﬂuoro-
scopy group.
Technique for PAC Flotation in the
Fluoroscopy Group
The technique for PAC ﬂotation in the ﬂuoroscopy group
was identical to that performed in the usual-care group;
however, before the commencement of ﬂoating the PAC, the
video ﬂuoroscopy machine was positioned over the patient,
enabling direct visualization of the course of the PAC from the
distal end of the PAC sheath to the PA. Video ﬂuoroscopy was
used to visualize catheter positioning from the SVC into the
RA, into the RV, and then into the PA. Video ﬂuoroscopy
demonstrating ﬂotation of the PAC in a patient undergoing re-
do cardiac surgery is presented in Figure 1 and Video 1. If the
PAC was unable to be ﬂoated into the PA within 10 minutes,
patients were transferred to the usual-care group.
After the PAC was inserted in both groups, anesthesia was
induced using a standardized opioid induction technique
(fentanyl, 10 ug/kg). After intubation of the patient’s trachea,
an independent echocardiographer, who was blinded to the
randomization and was not present during the PAC insertion,
performed standardized TEE views to ascertain the position of
the PAC in the main PA, proximal or distal right PA, or








Age (yr) 65 (15.2) 66 (9.5)
Sex
Male 15 (60%) 17 (58%)
BMI (kg/m2) 27 (5.3) 28 (9.7)
NYHA classiﬁcation (median) 3 3
Indications for Surgery
Ischemic heart disease 9 (36%) 7 (28%)
Isolated aortic valve 1 (4%) 2 (4%)
Isolated mitral valve 2 (8%) 3 (12%)
Combined aortic and mitral valves 6 (24%) 7 (28%)
Combined mitral and tricuspid
valves
4 (16%) 3 (12%)
Ischemic heart disease and valve
disease
3 (12%)
Redo surgery: number (%) 6 (24%) 7 (35%)
Previous tricuspid valve
annuloplasty
0 (0%) 0 (0%)
Previous right-sided cardiac
surgery
0 (0%) 0 (0%)
EuroSCORE II: mean (SD) 10.07 (2.5) 9.6 (2.3)
Preoperative Echocardiography
LV systolic function 6 (24%) 7 (28%)
Normal 2 (8%) 2 (8%)
Mild 11 (44%) 10 (40%)
Moderate 6 (24%) 6 (24%)
Severe
LV Diastolic Impairment
Normal 3 (12%) 2 (8%)
Grade 1 6 (24%) 7 (28%)
Grade 2 16 (64%) 15 (60%)
Grade 3 2 (8%) 1 (4%)
LA size (cm2) 26.3 (7.1) 28.8 (10.8)
PASP (mmHg) 40 (13.5) 49.8 (16.3)
Tricuspid Valve Insufﬁciency
Nil 5 (20%) 6 (24%)
Mild 14 (56%) 10 (40%)
Moderate 5 (20%) 7 (28%)
Severe 1 (4%) 2 (8%)
Preoperative Cardiac Catheterization
LVEDP (mmHg) 20.2 (9.55) 21.9 (9.95)
LV dilation
Dilated 11 (44%) 12 (44%)
Normal 14 (56%) 13 (56%)
LV Systolic Function
Normal 6 (24%) 5 (20%)
Mild dysfunction 3 (12%) 3 (12%)
Moderate dysfunction 11 (44%) 9 (36%)
Severe dysfunction 6 (24%) 8 (32%)
Coronary Occlusive Disease
Normal 12 (44%) 15 (60%)
Double-vessel 8 (32%) 7 (28%)
Triple-vessel 5 (20%) 3 (12%)
NOTE. Values are expressed as number of patients (proportion [%])
or mean (standard deviation), unless otherwise stated.
Abbreviations: BMI, body mass index; LA, left atrium; LV, left
ventricle; LVEDP, left ventricle end-diastolic pressure; NYHA, New
York Heart Association; PASP, pulmonary artery systolic pressure.
VIDEO FLUOROSCOPY FOR POSITIONING OF PULMONARY ARTERY CATHETERS 1513proximal left PA. The evaluation of arrhythmias from the
continuous ECG recordings was performed by a cardiologist
blinded to the intervention.
Variables collected included patient baseline characteristics,
indication for procedure, baseline cardiac structure and func-
tion, resting pulmonary artery pressures, EuroSCORE II
measurements, and routine hematologic and biochemical func-
tion test values. The primary outcome was time taken to ﬂoat
and position the PAC balloon in the PA. The time taken to
insert the PAC sheath, suture the sheath to the patient’s neck,
ﬂush each lumen of the PAC, and connect the distal lumen of
the PAC to the monitor were not included in this measurement.
Secondary outcomes included the number of attempts at
ﬂotation; rate of complications, deﬁned as either the occurrence
of any malignant arrhythmia (sustained or non-sustained
ventricular tachycardia, ventricular ﬁbrillation, or any supra-
ventricular tachyarrhythmia) or malposition of the PAC dem-
onstrated using TEE. An “attempt” was deﬁned as the necessity
to withdraw the catheter back into the RV, RA, or SVC to
assist with PAC insertion. “Malposition” was deﬁned as the
ﬁnal position of the deﬂated PAC balloon resting in the RA,
RV, or RV outﬂow tract or the deﬂated PAC balloon being
greater than 4 cm beyond the main PA bifurcation (increased
risk of inadvertent wedging and PA rupture). Other data
collected included delay in getting the video ﬂuoroscope into
the room, time taken to position the video ﬂuoroscope, time
taken to remove the video ﬂuoroscope from the room, and the
total radiation dose that each patient received.
Power Analysis
Based on surveillance data of high-risk patients who
underwent cardiac surgery and PAC insertion in the authors’
institution, the mean time to ﬂoat a PAC into the PA was 320
seconds (SD ¼ 130 seconds). Assuming a standard deviation in
both groups (video ﬂuoroscopy and usual-care groups) of 130
seconds, a sample size of 20 patients in each group was
required for a power of 90%, a statistical signiﬁcance level of
0.05, and to detect a clinically important difference of 50%
between the interventions (video ﬂuoroscopy and usual care).
A total of 25 patients were enrolled in each group.
Continuous data were tested for normality. Measures of
central tendency were compared as means  standard deviations
(SD), using the Student’s t-test for normally distributed varia-
bles, and as medians (interquartile range [IQR]) using the Mann-
Whitney U test for skewed data. Categorical variables were
compared using the chi-square test or the Fisher’s exact test for
no5. Logistic regression analysis was performed to determine
the predictive ability of video ﬂuoroscopy, preoperative cardiac
function, pulmonary hypertension, and left atrial size for
determining prolonged catheter ﬂotation or complications (eg,
catheter malposition or arrhythmias). Univariate and multivariate
techniques were used. Multivariate associations were reported as
odds ratios (OR) with 95% conﬁdence intervals. A 2-sided p
value ofo0.05 was considered statistically signiﬁcant. All
analyses were performed using SPSS Statistics for Windows,
Version 22.0 (IBM, Armonk, NY). This study is reported in
accordance to the CONSORT guidelines.
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Fifty high-risk patients undergoing cardiac surgery neces-
sitating PAC insertion consented to this study. Twenty-ﬁve
patients were assigned randomly to the ﬂuoroscopy group and
25 to the usual-care group. There were no breaches in the study
protocol, and all patients completed the interventions. Both
groups were similar with respect to baseline characteristics,
EuroSCORE II measurements, New York Heart Association
classiﬁcation of heart failure, tricuspid valve insufﬁciency,
severity of LV and RV dysfunction, RV and LV end-
diastolic pressures and dimensions, LA and RA size, and PA
systolic pressure (Table 1). Cardiac output measurements were
performed via a right heart catheter study in 6 patients during
preoperative cardiac catheterization. Only 2 patients, both in
the video ﬂuoroscopy group, had a cardiac indexo1.5 L/min/m2.
No patients in either group had undergone previous right-sided
cardiac surgery. The PAC was inserted via the right internal
jugular vein of all patients.
Mean (SD) time to ﬂoat the PAC was signiﬁcantly shorter
in the ﬂuoroscopy group: 73 seconds (SD, 65.1) versus 176
seconds (SD, 180.6) in the usual-care group; p ¼ 0.014. The
median (IQR) number of attempts to successful ﬂotation was
lower in the ﬂuoroscopy group: 1 (IQR, 1:2) attempts versus
2 (IQR, 1:4) attempts in the usual-care group; p ¼ 0.007.
There was no signiﬁcant difference in the number of patients
who experienced an arrhythmia during PAC insertion (8
patients in the usual-care group v 4 patients in the ﬂuoro-
scopy group; p ¼ 0.32). The composite complication rate
(malposition and arrhythmias) was greater in the usual-care
group than in the ﬂuoroscopy group (52% v 16%, respec-
tively; p ¼ 0.01). Although there were no overall differences
between the groups regarding ﬁnal position of the PAC in the
PA, in patients in whom the PAC was positioned distal to the
PA bifurcation, the mean (SD) position was farther from the
PA in the usual-care group compared with that in the
ﬂuoroscopy group (2.4 cm v 1.8 cm, respectively; estimated
difference, 0.6 cm; p ¼ 0.041). The PAC was unable to be
ﬂoated into the PA in 1 patient in the usual-care group and
that patient was transferred to the video ﬂuoroscopy group;
the catheter then was ﬂoated successfully in 56 seconds usingTable 2. Study
Mean time to ﬂoat (seconds)
Median number of attempts to position the PAC
Arrhythmias
Final position of the PAC in all patients
 Proximal to the bifurcation
 At the level of the bifurcation
 Distal to the bifurcation
Distance (cm) of the PAC balloon from the PA bifurcation
 Proximal to the bifurcation
 Distal to the bifurcation
Number of patients in whom the PAC was repositioned
Number of patients with either a catheter malposition or an arrhythmia
NOTE. Values are expressed as mean (standard deviation), median (int
Abbreviations: PA, pulmonary artery; PAC, pulmonary artery catheter.video ﬂuoroscopy. A summary of the key study endpoints is
summarized in Table 2.
There was a delay in access to ﬂuoroscopy in 3 patients. For
these patients, the delay was 6, 4, and 6 minutes, respectively.
The median time in setting up the video ﬂuoroscope was 4
minutes (IQR, 3.2:5.5). The median ﬂuoroscopy exposure time
was 58 seconds (IQR, 32:89). The median total effective dose
of radiation was 1.7 mSv (IQR, 1:2.2).
DISCUSSION
The authors performed a single-center, randomized, con-
trolled study in high-risk patients undergoing cardiac surgery,
comparing ﬂotation of a PAC with the aid of video ﬂuoroscopy
with the conventional technique of pressure waveform analysis
alone. Even though it previously has been suggested that use of
an image intensiﬁer can reduce the incidence of mechanical
complications of PAC insertion,3 there are no studies directly
comparing the ﬂotation of PACs using video ﬂuoroscopy with
a conventional pressure waveform technique. The authors
found that use of video ﬂuoroscopy required fewer attempts
to ﬂoat the PAC into the PA, was quicker, was more accurate,
and was associated with fewer complications. To the authors’
knowledge, this was the ﬁrst study directly comparing pressure
waveform analysis with ﬂuoroscopy assistance for insertion of
a PAC in adult patients considered to be at high risk for
difﬁcult PAC insertion.
This study conﬁrmed that the use of video ﬂuoroscopy-
guided insertion of a PAC in high-risk cardiac surgery patients
was associated with a clinically and statistically signiﬁcant
reduction in the time taken to position the device successfully.
This was highlighted by the experience of 1 patient who started
in the usual-care group and in whom it proved impossible to
ﬂoat the catheter during the allotted 10 minutes. The patient
was transferred to the ﬂuoroscopy group, and the device was
positioned correctly in 56 seconds. Use of video ﬂuoroscopy
also was associated with a reduction in complications, specif-
ically malposition and ventricular arrhythmia.
In both groups of patients, the ﬁnal position of the PAC was
distal to the PA bifurcation. However, the PAC was positioned






176 (180.6) 73.2 (65.1) 0.014
2 (1:4) 1 (1:2) 0.01
8 (32%) 4 (16%) 0.32
3 (12%) 4 (16%) 1.0
4 (16%) 6 (24%) 0.72
17 (68%) 15 (60%) 0.55
2.3 (0.9) 0.8 (0.3) 0.0001
2.4 (0.8) 1.8 (0.8) 0.041
7 (28%) 0 (0%) 0.01
13 (52%) 4 (16%) 0.01
erquartile range), or number of patients (proportion [%]).
Fig 3. Video ﬂuoroscopy image demonstrating the pulmonary
artery catheter tip coiling in the right atrium.
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PA trauma and hemorrhage. PA rupture is more common if the
PAC is positioned deep into the PA, especially with the balloon
overinﬂated while in the wedged position—a complication
reported to occur in only 0.2% of patients, but associated with
a 50% mortality rate.4 Similarly, if the PAC is positioned too
proximal to the PA bifurcation (ie, close proximity to the
pulmonary valve—a ﬁnding observed in the usual-care group),
complications can include pulmonary valve trauma and migration
of the catheter into the RV with subsequent ventricular arrhyth-
mias, which, even though usually transient, can convert to
sustained ventricular tachycardia.
From the authors’ pilot data, based on surveillance data of
high-risk patients undergoing cardiac surgery who received a
PAC in the authors’ institution, the mean time to ﬂoat the
catheter into the PA was 320 seconds, with a fairly wide
standard deviation. Pilot data took into account “all comers”
inserting a PAC (eg, senior anesthesiology trainees and junior
attending cardiac anesthesiologists). It was not unexpected that
in the usual-care group, the mean time to insert the PAC was
shorter than the pilot data stated.
The beneﬁts of using ﬂuoroscopy therefore should always
outweigh the potential limitations. There are many advantages to
the use of ﬂuoroscopy for the insertion of a PAC, particularly in
patients in whom ﬂotation is predicted to be difﬁcult due to
abnormal ﬂow in the heart (eg, atrial or ventricular septal defects
or low-cardiac-output states). First, ﬂuoroscopy provides real-time
visualization of the catheter as it traverses the right heart, allowing
early recognition of malposition. In particular, entry of the catheter
into the left subclavian vein (Figure 2 and Video 2) or inferior
vena cava or coiling in the RA or RV (Figures 3 and 4 and Video 3)
are recognized rapidly, and this allows for prompt and accurate
redirection of the catheter. Secondly, coiling or knotting of the
catheter is prevented, notably by recognition of excessive insertion
length. Finally, ﬂuoroscopy facilitates better accuracy in conﬁrm-
ing that the PAC sits in an ideal position within the main PA,Fig 2. Video ﬂuoroscopy image demonstrating the pulmonary
artery catheter tip in the left subclavian vein.sufﬁciently distal to the pulmonary valve, thus minimizing
arrhythmias and avoiding excessive proximal insertion into a
smaller PA branch. This minimizes the risk of PA perforation
through inadvertent catheter “wedging.” Prolonged catheterization
time also is a recognized risk factor for ventricular arrhythmias
during PAC insertion,5,6 and excessive insertion length is the
major contributing factor to catheter knotting. Hence, the use of
ﬂuoroscopy during PA insertion in cardiac surgery patients at
higher risk of a PAC-related complication is a pragmatic, rational,
and feasible intervention to minimize complications.
When using ﬂuoroscopy in this setting, it is important to
minimize the patient radiation dose. In this study, additional
strategies to reduce radiation exposure to the patient and
anesthesiologist included minimizing the use of the following:
steep angles of x-ray beam, magniﬁcation modes, frame rates of
ﬂuoroscopy, and cine.7 A maximum distance of operator and
patient from the x-ray source was maintained, and the radiation
ﬁeld was minimized to include only the anatomic region of
interest because proper collimation of the x-ray beam substan-
tially decreases patient dose.8,9 This study involved the addi-
tional exposure of radiation of up to 300 seconds of video
ﬂuoroscopy in patients for the purpose of image-guided
insertion of the PAC. Based on a single session of fewer than
5 minutes, ﬂuoroscopic time, at a 20 mGy/min dose rate, a
radiation beam of 20-cm diameter, and air gap to ﬂat panel of 5
cm, the authors estimated that patients may have received a
radiation dose of approximately 3.5 mSv2. Most people during
normal daily activities are exposed to naturally occurring
background radiation and receive a dose of radiation of about
2 mSv each year. The effective dose from this study dose was
1.7 mSv. The dose is comparable with that received during
many other diagnostic medical x-ray and nuclear medicine
procedures.10 At the dose level used during this study, no
harmful effects of radiation have been demonstrated because
any effect is too small to measure. The additional risk of an
induced fatal cancer is believed to be low and theoretically is
approximately equivalent to 1 in 4,200.10 To justify the risks
involved, a moderate beneﬁt therefore still needs to be
demonstrated. In the context of this study, the beneﬁts of using
Fig 4. Video ﬂuoroscopy image demonstrating the pulmonary
artery catheter tip coiling in the right atrium.
WEINBERG ET AL1516ﬂuoroscopy (ie, faster insertion times and decreased rates of
complications) outweighed the risks of radiation.
The authors’ ﬁndings have important implications for PA
catheterization in cardiac surgery, particularly as hybrid operat-
ing rooms become increasingly widespread. Lack of availability
and expense commonly are cited as reasons for not using
ﬂuoroscopy for PAC insertion. These were not considered to be
prohibitive factors in using ﬂuoroscopy at the authors’ institu-
tion. Even though the authors’ institution does not have hybrid
operating room capability, the availability of an image intensi-
ﬁer in the cardiac operating room at all times with dedicated
radiology technician support allowed minimal delay in access to
the intensiﬁer and a relatively fast set-up time. These factors
may be more prohibitive in other institutions.
During PAC insertion, all patients were conscious and cooper-
ative. Insertion of lines while patients were awake and before the
induction of anesthesia allowed greater hemodynamic stability
because patients were not under the inﬂuences of anesthetic
medications or vasoactive or antiarrhythmic drugs. Even though
study design, standardization of patient positioning, type and make
of PAC, rate of PAC insertion, and rescue strategies used were
systematic and well controlled—increasing the internal validity of
this trial—there were several limitations to the study. First, it wasnot possible to blind the anesthesiologist performing the PAC
insertion to the technique being used. Observer effect, or an
observer expectancy effect, unconsciously may have inﬂuenced
the anesthesiologists’ ﬂotation technique, resulting in a form of
reactivity and cognitive bias during PAC ﬂotation and potentially
providing more care or attention to patients in 1 particular group.
However, all anesthesiologists performing the PAC ﬂotation are
equally skilled in both techniques, have a diverse range of
clinical expertise in using both video ﬂuoroscopy and traditional
waveform analyses techniques, and have clinical equipoise for
the research question. Second, it is not possible to generalize the
results of this study to clinicians inexperienced in the use of
either PAC insertion using traditional waveform analyses or
clinicians inexperienced with the use and interpretation of video
ﬂuoroscopy. Because patient selection was limited to a cardiac
surgery population considered to be at high risk of PAC-related
complications and from a single center, it was not possible to
generalize the results to other groups of cardiac patients or to
other settings where PAC is used, such as the intensive care unit.
Finally, economic analysis of all costs (presence of a radiogra-
pher, time taken to position the image intensiﬁer, and use of
additional equipment) was not performed; however, this did not
detract from the study objectives or the ﬁndings reported.
Indeed, it could be argued that the lower incidence of compli-
cations resulting from this technique may contribute to a
potential overall pharmacoeconomic cost beneﬁt.
CONCLUSIONS
In patients considered at higher risk for PAC-related complica-
tions who are undergoing cardiac surgery, video ﬂuoroscopy
facilitated faster and safer PAC ﬂotation and positioning compared
with the traditional pressure waveform ﬂotation technique alone.
Clinicians should have a low threshold to use video ﬂuoroscopy as
a complementary technique when the positioning of a PAC using
the traditional waveform approach is anticipated to be difﬁcult.
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